Ontology highlight
ABSTRACT:
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell, Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Vollter Anastas
LAB HEAD: Philip N.
PROVIDER: PXD046970 | Pride | 2023-11-22
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
Control_Versus_shKDM2B_proteomics.xlsx | Xlsx | |||
S22030-fraction-1-Aug03.raw | Raw | |||
S22030-fraction-1-July25.raw | Raw | |||
S22030-fraction-10-Aug03.raw | Raw | |||
S22030-fraction-10-July25.raw | Raw |
Items per page: 5 1 - 5 of 23 |
Chavdoula Evangelia E Anastas Vollter V La Ferlita Alessandro A Aldana Julian J Carota Giuseppe G Spampinato Mariarita M Soysal Burak B Cosentini Ilaria I Parashar Sameer S Sircar Anuvrat A Nigita Giovanni G Sehgal Lalit L Freitas Michael A MA Tsichlis Philip N PN
Metabolism: clinical and experimental 20231106
<h4>Introduction</h4>KDM2B encodes a JmjC domain-containing histone lysine demethylase, which functions as an oncogene in several types of tumors, including TNBC. This study was initiated to address the cancer relevance of the results of our earlier work, which had shown that overexpression of KDM2B renders mouse embryonic fibroblasts (MEFs) resistant to oxidative stress by regulating antioxidant mechanisms.<h4>Methods</h4>We mainly employed a multi-omics strategy consisting of RNA-Seq, quantita ...[more]